Study of miRNA interactome in active rheumatoid arthritis patients reveals key pathogenic roles of dysbiosis in the infection-immune network.
bioinformatics
biomarkers
circulating microRNA
infection-immune network
interactome
intestinal microbiome
rheumatoid arthritis
Journal
Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501
Informations de publication
Date de publication:
02 03 2021
02 03 2021
Historique:
received:
14
11
2019
revised:
16
05
2020
pubmed:
11
9
2020
medline:
30
6
2021
entrez:
10
9
2020
Statut:
ppublish
Résumé
To characterize serum microRNA (miR) and the miR interactome of active RA patients in RA aetiology and pathogenesis. The differentially expressed miRs (DEmiRs) in serum of naïve active RA patients (NARAPs, n = 9, into three pools) vs healthy controls (HCs, n = 15, into five pools) were identified with Agilent human miR microarray analysis. Candidate driver genes in epigenetic and pathogenic signalling pathway modules for RA were analysed using miRTarBase and a molecular complex detection algorithm. The interactome of these DEmiRs in RA pathogenesis were further characterized with gene ontology and Kyoto Encyclopaedia of Genes and Genomes. Three upregulated DEmiRs (hsa-miR-187-5p, -4532, -4516) and eight downregulated DEmiRs (hsa-miR-125a-3p, -575, -191-3p, -6865-3p, -197-3p, -6886-3p, -1237-3p, -4436b-5p) were identified in NARAPs. Interactomic analysis from heterogeneous experimentally validated sources yielded 1719 miR-target interactions containing 5.67% strong and 94.33% less strong experimental evidence. Gene ontology and Kyoto Encyclopaedia of Genes and Genomes analyses allocated the upregulated DEmiRs in the infection modules and the downregulated DEmiRs in the immune signalling pathways. Specifically, these DEmiRs revealed the significant contributions of the intestinal microbiome dysbiosis in the infection-inflammation-immune network for activation of T cells, immune pathways of IL-17, Toll-like receptor, TNF, Janus kinase-signal transducer and activator of transcription, osteoclast cell differentiation pathway and IgA production to the active RA pathogenesis. Our experiment-based interactomic study of DEmiRs in serum of NARAPs revealed novel clinically relevant miRs interactomes in the infection-inflammation-immune network of RA. These results provide valuable resources for understanding the integrated function of the miR network in RA pathogenesis and the application of circulating miRs as biomarkers for early aetiologic RA diagnosis.
Identifiants
pubmed: 32910145
pii: 5903551
doi: 10.1093/rheumatology/keaa369
pmc: PMC7937024
doi:
Substances chimiques
MicroRNAs
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1512-1522Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology.
Références
PLoS One. 2018 Aug 8;13(8):e0201217
pubmed: 30089130
Int J Mol Sci. 2016 Jun 08;17(6):
pubmed: 27338350
Front Genet. 2019 Jun 14;10:570
pubmed: 31258550
Ann Rheum Dis. 2014 Oct;73(10):1898-904
pubmed: 23897768
JAMA. 2018 Oct 02;320(13):1360-1372
pubmed: 30285183
Arthritis Rheum. 2008 Apr;58(4):1001-9
pubmed: 18383392
Trans Am Clin Climatol Assoc. 2018;129:171-182
pubmed: 30166712
Ann Rheum Dis. 2019 Dec;78(12):1609-1615
pubmed: 31434637
J Autoimmun. 2019 May;99:104-115
pubmed: 30850234
Int J Mol Sci. 2016 Mar 22;17(3):431
pubmed: 27011180
J Cell Physiol. 2014 Nov;229(11):1630-8
pubmed: 24610393
Clin Chim Acta. 2017 Oct;473:106-115
pubmed: 28842173
Clin Exp Rheumatol. 2019 Sep-Oct;37(5):886-887
pubmed: 31172919
Arthritis Res Ther. 2016 Aug 24;18:189
pubmed: 27558398
Stem Cells. 2018 Mar;36(3):434-445
pubmed: 29239062
J Immunol Res. 2018 Mar 29;2018:2474529
pubmed: 29785401
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Biomed Res Int. 2017;2017:6484835
pubmed: 28913356
N Engl J Med. 2011 Dec 8;365(23):2205-19
pubmed: 22150039
Front Immunol. 2019 Jun 27;10:1475
pubmed: 31316517
J Autoimmun. 2015 May;59:85-90
pubmed: 25819755
Cell Mol Immunol. 2018 Jun;15(6):595-609
pubmed: 29706647
Arthritis Rheum. 2009 May;60(5):1294-304
pubmed: 19404929
PeerJ. 2018 Oct 11;6:e5743
pubmed: 30324023
Nucleic Acids Res. 2018 Jan 4;46(D1):D296-D302
pubmed: 29126174
Methods Mol Biol. 2016;1358:229-51
pubmed: 26463387
Nat Protoc. 2019 Feb;14(2):482-517
pubmed: 30664679
Clin Dev Immunol. 2013;2013:296139
pubmed: 24151514
Scand J Clin Lab Invest. 2019 Feb - Apr;79(1-2):7-16
pubmed: 30727744
Mol Biol Cell. 2018 Jul 15;29(13):1682-1692
pubmed: 29791254
BMC Genomics. 2015;16 Suppl 2:S12
pubmed: 25707768
Cold Spring Harb Perspect Biol. 2018 Aug 1;10(8):
pubmed: 30068528
Acta Pharmacol Sin. 2018 Nov;39(11):1787-1796
pubmed: 30181579
Clin Exp Rheumatol. 2017 Mar-Apr;35(2):221-228
pubmed: 27749223
Lancet. 2017 Jun 10;389(10086):2328-2337
pubmed: 28612747
PLoS One. 2014 Sep 10;9(9):e107467
pubmed: 25208211
Front Immunol. 2018 Apr 10;9:702
pubmed: 29692777
Cell. 2014 Aug 28;158(5):1000-1010
pubmed: 25171403
DNA Cell Biol. 2016 Dec;35(12):853-860
pubmed: 27875659
Ther Adv Musculoskelet Dis. 2018 Jun;10(5-6):117-127
pubmed: 29942363
Autoimmun Rev. 2015 Nov;14(11):1029-37
pubmed: 26164649
BMC Bioinformatics. 2003 Jan 13;4:2
pubmed: 12525261
Ann Rheum Dis. 2011 Mar;70 Suppl 1:i92-6
pubmed: 21339228
Zhonghua Yi Xue Za Zhi. 2011 Mar 8;91(9):639-42
pubmed: 21600139